Khoom hauv
Eli Lilly
thiab
Novo Nordisk
outperformed xyoo tas los, loj vim yog qhov kev thov zoo kawg nkaus rau cov tshuaj tshiab uas ua rau kom poob phaus hauv cov neeg mob uas muaj ntshav qab zib thiab rog rog.
Ob leeg stocks tau qis dua lub lim tiam no, tom qab cov tuam txhab tau tshaj tawm lub Kaum Ob Hlis Ntuj cov txiaj ntsig. Lilly (ticker: LLY) tau tawm 4% txog rau hnub Thursday, txog $ 330.70, ntawm cov neeg ua lag luam poob siab tias lub quarter muag tau cuam tshuam los ntawm kev txo qis rau lub tuam txhab Covid tshuaj tiv thaiv. Novo (
NVO
) swb 6% rau hnub Thursday kaw ntawm $132.34.
Tau qhov twg los: https://www.barrons.com/articles/lilly-novo-stock-diet-drugs-earnings-51675376265?siteid=yhoof2&yptr=yahoo